BG103740A - Phytostyrene composition for the prevention of the alzheimer's disease - Google Patents
Phytostyrene composition for the prevention of the alzheimer's diseaseInfo
- Publication number
- BG103740A BG103740A BG103740A BG10374099A BG103740A BG 103740 A BG103740 A BG 103740A BG 103740 A BG103740 A BG 103740A BG 10374099 A BG10374099 A BG 10374099A BG 103740 A BG103740 A BG 103740A
- Authority
- BG
- Bulgaria
- Prior art keywords
- composition
- phytostyrene
- alzheimer
- disease
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/993,901 US5985936A (en) | 1997-12-18 | 1997-12-18 | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
PCT/CA1998/001147 WO1999032097A2 (fr) | 1997-12-18 | 1998-12-18 | Procede pour prevenir et retarder l'apparition de la maladie d'alzheimer, et composition utilisee a cet effet |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103740A true BG103740A (en) | 2000-05-31 |
Family
ID=25540052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103740A BG103740A (en) | 1997-12-18 | 1999-09-17 | Phytostyrene composition for the prevention of the alzheimer's disease |
Country Status (18)
Country | Link |
---|---|
US (1) | US5985936A (fr) |
EP (1) | EP0967982A2 (fr) |
CN (1) | CN1252724A (fr) |
AU (1) | AU1656099A (fr) |
BG (1) | BG103740A (fr) |
BR (1) | BR9807577A (fr) |
CA (1) | CA2281710A1 (fr) |
EE (1) | EE9900354A (fr) |
GE (1) | GEP20022783B (fr) |
HU (1) | HUP0100737A3 (fr) |
LT (1) | LT4801B (fr) |
LV (1) | LV12438B (fr) |
MD (1) | MD1920F2 (fr) |
NO (1) | NO993979L (fr) |
PL (1) | PL335421A1 (fr) |
RU (1) | RU2173151C2 (fr) |
SK (1) | SK112999A3 (fr) |
WO (1) | WO1999032097A2 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
NZ518822A (en) * | 1999-11-04 | 2004-12-24 | Andrx Corp | Treating a mammal with an APP processing disorder such as Alzheimer's Disease and Down's Syndrome by administering at least one HMG-CoA reductase inhibitor |
KR20030005280A (ko) | 2000-04-14 | 2003-01-17 | 마아즈, 인코오포레이티드 | 혈관의 건강을 개선하기 위한 조성물과 방법 |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
WO2002064735A2 (fr) * | 2001-02-12 | 2002-08-22 | Akzo Nobel N.V. | Methodes permettant d'ameliorer le traitement de depressions graves par genotypage visant a determiner le gene associe a l'apolipoproteine e4 et d'ameliorer la reponse therapeutique de personnes souffrant de depression grave et porteuses du gene associe a l'apolipoproteine e4 |
US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
DE10154221A1 (de) * | 2001-11-07 | 2003-05-15 | Max Delbrueck Centrum | Mittel zur Behandlung von Läsionen des Nervensystems |
FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
CA2517571C (fr) | 2003-03-07 | 2011-07-05 | Schering Corporation | Azetidinones substituees , procedes pour leur preparation, formulations et utilisations de celles-ci |
CA2517573C (fr) * | 2003-03-07 | 2011-12-06 | Schering Corporation | Composes d'azetidinone substitues, formulations et utilisations de ceux-ci pour traiter l'hypercholesterolemie |
WO2004081003A1 (fr) | 2003-03-07 | 2004-09-23 | Schering Corporation | Composes d'azetidinone substitues, leurs formulations et leur utilisation pour traiter l'hypercholesterolemie |
US20080182801A1 (en) * | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0513881D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
CA2555367A1 (fr) * | 2004-01-22 | 2005-08-11 | Genaissance Pharmaceuticals, Inc. | Marqueurs genetiques apoe associes a l'age de l'apparition de la maladie d'alzheimer |
EP1814575A4 (fr) * | 2004-11-24 | 2010-07-07 | Neopro Labs Llc | Methodes et compositions pour traiter des troubles |
GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
GB0513883D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
GB0513888D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
US20110053951A1 (en) * | 2008-03-27 | 2011-03-03 | Evotec Neurosciences Gmbh | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
WO2010104375A1 (fr) | 2009-03-12 | 2010-09-16 | N.V. Nutricia | Stigmastérol pour le traitement de la maladie d'alzheimer |
US10307450B2 (en) | 2010-01-11 | 2019-06-04 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
US10383886B2 (en) | 2010-01-11 | 2019-08-20 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with oleandrin |
US9011937B2 (en) * | 2010-11-22 | 2015-04-21 | Phoenix Biotechnology, Inc. | Method of treating neurological conditions with extract of Nerium species or Thevetia species |
WO2012149111A1 (fr) | 2011-04-26 | 2012-11-01 | The Regents Of The University Of California | Procédés de promotion de réparation neuronale du snc par inhibition de lrp-1 |
CN102813659A (zh) * | 2012-08-21 | 2012-12-12 | 贵阳中医学院 | 20α-二甲胺基- 2α-羟基-3β-惕洛酰胺基-5α-孕甾烷的用途 |
WO2015123618A1 (fr) * | 2014-02-14 | 2015-08-20 | Arizona Board Of Regents For The University Of Arizona | Procédé d'augmentation de l'expression du gène bcl2 |
US10702567B2 (en) | 2016-09-14 | 2020-07-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
US10596186B2 (en) | 2016-09-14 | 2020-03-24 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infections |
US11331291B2 (en) | 2017-09-14 | 2022-05-17 | Phoenix Biotechnology, Inc. | Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders |
JP7370966B2 (ja) | 2017-09-14 | 2023-10-30 | フェニックス・バイオテクノロジー・インコーポレイテッド | 神経学的状態を治療するための方法および改善された神経保護組成物 |
EP3842039A1 (fr) * | 2019-12-24 | 2021-06-30 | Folium Biosciences Europe B.V. | Complément alimentaire comprenant des cannbinoïdes et des phytostérols pour la maladie d'alzheimer |
EP4081198A1 (fr) | 2019-12-24 | 2022-11-02 | Folium Biosciences Europe B.V. | Complément alimentaire pour la maladie d'alzheimer |
US11806359B2 (en) | 2020-03-31 | 2023-11-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating Coronavirus infection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
AU6274394A (en) * | 1993-02-23 | 1994-09-14 | Pharmakon Usa, Inc. | Therapeutic herbal composition |
US5589182A (en) * | 1993-12-06 | 1996-12-31 | Tashiro; Renki | Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression |
PL186441B1 (pl) * | 1994-09-29 | 2004-01-30 | Univ British Columbia | Kompozycja obniżająca poziom cholesterolu, jej zastosowanie i zawierający ją produkt farmaceutyczny |
CN1179903A (zh) * | 1996-10-09 | 1998-04-29 | 李辉 | 营养丝米粉 |
ES2285772T3 (es) * | 1997-05-15 | 2007-11-16 | University Of Washington | Composicion y metodos para tratar la enfermedad de alzheimer y otras amiloidosis. |
-
1997
- 1997-12-18 US US08/993,901 patent/US5985936A/en not_active Expired - Fee Related
-
1998
- 1998-12-18 BR BR9807577-2A patent/BR9807577A/pt not_active IP Right Cessation
- 1998-12-18 WO PCT/CA1998/001147 patent/WO1999032097A2/fr not_active Application Discontinuation
- 1998-12-18 CA CA002281710A patent/CA2281710A1/fr not_active Abandoned
- 1998-12-18 PL PL98335421A patent/PL335421A1/xx unknown
- 1998-12-18 HU HU0100737A patent/HUP0100737A3/hu unknown
- 1998-12-18 EE EEP199900354A patent/EE9900354A/xx unknown
- 1998-12-18 EP EP98960959A patent/EP0967982A2/fr not_active Ceased
- 1998-12-18 SK SK1129-99A patent/SK112999A3/sk unknown
- 1998-12-18 CN CN98804259A patent/CN1252724A/zh active Pending
- 1998-12-18 AU AU16560/99A patent/AU1656099A/en not_active Abandoned
- 1998-12-18 MD MD99-0262A patent/MD1920F2/ro unknown
- 1998-12-18 GE GEAP19984990A patent/GEP20022783B/en unknown
- 1998-12-18 RU RU99120072/14A patent/RU2173151C2/ru not_active IP Right Cessation
-
1999
- 1999-08-18 NO NO993979A patent/NO993979L/no not_active Application Discontinuation
- 1999-09-16 LT LT1999114A patent/LT4801B/lt not_active IP Right Cessation
- 1999-09-17 BG BG103740A patent/BG103740A/xx unknown
- 1999-09-17 LV LVP-99-134A patent/LV12438B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9807577A (pt) | 2001-08-07 |
NO993979D0 (no) | 1999-08-18 |
PL335421A1 (en) | 2000-04-25 |
CN1252724A (zh) | 2000-05-10 |
WO1999032097A3 (fr) | 1999-09-02 |
CA2281710A1 (fr) | 1999-07-01 |
WO1999032097A2 (fr) | 1999-07-01 |
EE9900354A (et) | 2000-02-15 |
MD990262A (en) | 2000-06-30 |
MD1920F2 (ro) | 2002-05-31 |
NO993979L (no) | 1999-10-13 |
LV12438A (en) | 2000-03-20 |
AU1656099A (en) | 1999-07-12 |
US5985936A (en) | 1999-11-16 |
HUP0100737A3 (en) | 2002-07-29 |
RU2173151C2 (ru) | 2001-09-10 |
EP0967982A2 (fr) | 2000-01-05 |
HUP0100737A2 (hu) | 2001-09-28 |
SK112999A3 (en) | 2001-11-06 |
LT4801B (lt) | 2001-06-25 |
LV12438B (en) | 2000-09-20 |
GEP20022783B (en) | 2002-09-25 |
LT99114A (lt) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
MD1745B2 (en) | 4,5-dimethyl-N-2-propenyl-2-(trimethylsilyl)-3-thiophencarboxamide, fungicidal composition on base thereof and method of plants diseases control | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
MY132529A (en) | Paroxetine hydrochloride anhydrate | |
BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
OA09772A (en) | "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
BG105197A (en) | Polymorph form of a medicament | |
BG102589A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
BG102660A (en) | Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders | |
BG105275A (en) | Tan-1057 derivatives | |
CA2132544A1 (fr) | Antagonistes d'angiotensine ii utiles contre les troubles lies a une vitesse alteree de l'influx nerveux, particulierement dans le cas de la neuropathie diabetique | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
BG102667A (en) | Diosgenine-containing composition |